Skip to content
Recall Observatory FDA recall evidence

Drug product

Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by: Aenova Holding GmBh, Miami, Fl 33186, NDC 63739-0478-10

D-1007-2019

January 16, 2019

Class II

Product summary

Firm
Rx Pak Division of McKesson Corporation
Event
Event 81943
Status
Terminated
Classification
Class II
Quantity
29,622 Blister Cards
Official record key
drug-enforcement:D-1007-2019

Official wording

Reason: Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.

Code information: Lot # 0119397, Exp 02/2020

Distribution pattern: Product was distributed to 5 major distributors who may have further distributed the product throughout the United States.

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Label mix-up